BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodelo-Haad C, Santamaria R, Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Martin-Malo A, Rodriguez M. FGF23, Biomarker or Target? Toxins (Basel) 2019;11:E175. [PMID: 30909513 DOI: 10.3390/toxins11030175] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Rodelo-haad C, Muñoz-castañeda JR, Santamaria R, Martín-malo A. Iron repletion and FGF23 regulation. A potentially dangerous combination. Nefrología (English Edition) 2021;41:367-72. [DOI: 10.1016/j.nefroe.2021.11.001] [Reference Citation Analysis]
2 Vogt I, Haffner D, Leifheit-Nestler M. FGF23 and Phosphate-Cardiovascular Toxins in CKD. Toxins (Basel) 2019;11:E647. [PMID: 31698866 DOI: 10.3390/toxins11110647] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
3 Kondo Y, Komaba H, Fukagawa M. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease. Expert Rev Mol Diagn 2020;20:715-24. [PMID: 32513031 DOI: 10.1080/14737159.2020.1780918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Bosco F, Musolino V, Gliozzi M, Nucera S, Carresi C, Zito MC, Scarano F, Scicchitano M, Reale F, Ruga S, Maiuolo J, Macrì R, Guarnieri L, Coppoletta AR, Mollace R, Muscoli C, Palma E, Mollace V. The muscle to bone axis (and viceversa): An encrypted language affecting tissues and organs and yet to be codified? Pharmacol Res 2021;165:105427. [PMID: 33453372 DOI: 10.1016/j.phrs.2021.105427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Kaesler N, Babler A, Floege J, Kramann R. Cardiac Remodeling in Chronic Kidney Disease. Toxins (Basel) 2020;12:E161. [PMID: 32150864 DOI: 10.3390/toxins12030161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
6 Sanz B, Arrieta H, Rezola-Pardo C, Fernández-Atutxa A, Garin-Balerdi J, Arizaga N, Rodriguez-Larrad A, Irazusta J. Low serum klotho concentration is associated with worse cognition, psychological components of frailty, dependence, and falls in nursing home residents. Sci Rep 2021;11:9098. [PMID: 33907242 DOI: 10.1038/s41598-021-88455-6] [Reference Citation Analysis]
7 Deng J, Liu Y, Liu Y, Li W, Nie X. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy. J Inflamm Res 2021;14:5273-90. [PMID: 34703268 DOI: 10.2147/JIR.S334996] [Reference Citation Analysis]
8 Ewendt F, Hirche F, Feger M, Föller M. Peroxisome proliferator-activated receptor α (PPARα)-dependent regulation of fibroblast growth factor 23 (FGF23). Pflugers Arch 2020;472:503-11. [PMID: 32189072 DOI: 10.1007/s00424-020-02363-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Fargaly H, Mathew S, Rossi NF. Hyperglycinuria: diagnosis in middle age. BMJ Case Rep 2022;15:e246252. [PMID: 35236679 DOI: 10.1136/bcr-2021-246252] [Reference Citation Analysis]
10 Muñoz-Castañeda JR, Rodelo-Haad C, Pendon-Ruiz de Mier MV, Martin-Malo A, Santamaria R, Rodriguez M. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease. Toxins (Basel) 2020;12:E185. [PMID: 32188018 DOI: 10.3390/toxins12030185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
11 Rodríguez-Ortiz ME, Alcalá-Díaz JF, Canalejo A, Torres-Peña JD, Gómez-Delgado F, Muñoz-Castañeda JR, Delgado-Lista J, Rodríguez M, López-Miranda J, Almadén Y. Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study. Eur J Intern Med 2020;74:79-85. [PMID: 31899053 DOI: 10.1016/j.ejim.2019.12.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Meng F, Bertucci C, Gao Y, Li J, Luu S, LeBoff MS, Glowacki J, Zhou S. Fibroblast growth factor 23 counters vitamin D metabolism and action in human mesenchymal stem cells. J Steroid Biochem Mol Biol 2020;199:105587. [PMID: 32004706 DOI: 10.1016/j.jsbmb.2020.105587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Neyra JA, Hu MC, Moe OW. Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications. Clin J Am Soc Nephrol 2020;16:162-76. [PMID: 32699047 DOI: 10.2215/CJN.02840320] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Wang H, Zheng X, Zhang Y, Huang J, Zhou W, Li X, Tian H, Wang B, Xing D, Fu W, Chen T, Wang X, Zhang X, Wu A. The endocrine role of bone: Novel functions of bone-derived cytokines. Biochem Pharmacol 2021;183:114308. [PMID: 33137323 DOI: 10.1016/j.bcp.2020.114308] [Reference Citation Analysis]
15 Gembillo G, Cernaro V, Siligato R, Curreri F, Catalano A, Santoro D. Protective Role of Vitamin D in Renal Tubulopathies. Metabolites 2020;10:E115. [PMID: 32204545 DOI: 10.3390/metabo10030115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
16 Miyakawa H, Hsu HH, Ogawa M, Akabane R, Miyagawa Y, Takemura N. Association between serum fibroblast growth factor-23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease. J Vet Intern Med 2021;35:2296-305. [PMID: 34418162 DOI: 10.1111/jvim.16237] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Miyakawa H, Hsu HH, Ogawa M, Akabane R, Miyagawa Y, Takemura N. Association between serum fibroblast growth factor-23 concentrations and blood calcium levels in chronic kidney disease cats with upper urolithiasis. J Feline Med Surg 2022;:1098612X221075278. [PMID: 35133180 DOI: 10.1177/1098612X221075278] [Reference Citation Analysis]
18 Thongprayoon C, Neyra JA, Hansrivijit P, Medaura J, Leeaphorn N, Davis PW, Kaewput W, Bathini T, Salim SA, Chewcharat A, Aeddula NR, Vallabhajosyula S, Mao MA, Cheungpasitporn W. Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis. J Clin Med 2020;9:E1834. [PMID: 32545510 DOI: 10.3390/jcm9061834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Rodelo-Haad C, Muñoz-Castañeda JR, Santamaria R, Martín-Malo A. Iron repletion and FGF23 regulation. A potentially dangerous combination. Nefrologia 2021;41:367-72. [PMID: 33888349 DOI: 10.1016/j.nefro.2021.03.001] [Reference Citation Analysis]
20 Kužmová Z, Kužma M, Gažová A, Kovářová M, Jackuliak P, Killinger Z, Kyselovič J, Payer J. Fibroblast Growth Factor 23 and Klotho Are Associated With Trabecular Bone Score but Not Bone Mineral Density in the Early Stages of Chronic Kidney Disease: Results of the Cross-Sectional Study. Physiol Res 2021;70:S43-51. [PMID: 34918528 DOI: 10.33549/physiolres.934773] [Reference Citation Analysis]